Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections

Cristina Cigana1, Nicola Ivan Lorè1, Camilla Riva1

  • 1Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milano, Italy.

Scientific Reports
|February 18, 2016
PubMed

Insights

Pseudomonas aeruginosa adaptive variants in cystic fibrosis (CF) lung disease promote bacterial persistence by influencing the immune response. A new chronic infection mouse model reveals how bacterial persistence drives CF lung pathology and fibrosis.

Area of Science:

  • Microbiology
  • Immunology
  • Pathology

Background:

  • Cystic fibrosis (CF) lung disease is characterized by recurrent Pseudomonas aeruginosa infections, host immune responses, and tissue injury.
  • P. aeruginosa adapts to the CF lung environment, but the role of bacterial adaptive variants in disease progression remains unclear.

Purpose of the Study:

  • To investigate the influence of P. aeruginosa adaptive variants on the host immune response and bacterial persistence.
  • To develop and utilize a refined murine model of chronic P. aeruginosa infection to study CF lung disease pathogenesis.

Main Methods:

  • In vitro and murine infection models were used to assess P. aeruginosa adaptive variants' impact on the innate immune response.
  • A chronic pneumonia murine model, including CFTR-deficient mice, was established to mimic P. aeruginosa chronic infection for up to three months.

Main Results:

  • P. aeruginosa CF-adaptive variants were shown to modulate the innate immune response, promoting their own persistence.
  • The refined murine model demonstrated that P. aeruginosa persistence leads to CF hallmarks such as airway remodeling, fibrosis, epithelial hyperplasia, and tissue damage.

Conclusions:

  • P. aeruginosa persistence, driven by adaptive variants, significantly contributes to CF lung pathology, including airway remodeling and fibrosis.
  • The developed chronic infection mouse model accurately reproduces key aspects of CF lung disease and serves as a valuable tool for pre-clinical studies targeting inflammation and tissue damage.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
33
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.0K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.4K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
12
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K